- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01617499
Physical Activity for Campus Employees (PACE)
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Cardiovascular disease (CVD) persists as the leading cause of mortality in the United States and accounts for 17 percent of the nation's overall health expenditures. Although the mortality rate of CVD has declined in recent years, the burden of disease remains high. Currently, 1 in 3 Americans has some form of CVD. Additionally, according to a recent policy statement published by the American Heart Association (AHA), 40% of the population is projected to have some form of CVD by 2030. Furthermore, the AHA has projected that the cost to treat CVD will triple by 2030. The prevalence and rising financial burden of CVD demonstrate the urgency for effective implementation of disease prevention strategies.
Evidence suggesting the majority of CVD is preventable through modifiable risk factor management continues to grow. Nonetheless, difficulty controlling modifiable risk factors remains an issue for many Americans. The magnitude of this challenge is supported by a study revealing that 78% of adults are candidates for at least one CVD prevention activity. Although national organizations have published a variety of disease prevention recommendations, widespread implementation of and adherence to preventative programs remain problematic. Consequently, a large proportion of the population is not receiving or participating in prevention strategies from which they may benefit. The full potential of reducing the nation's CVD burden cannot be achieved unless interventions are implemented on a larger scale, with reduced costs, and with increased initial and continued participation.
With approximately 130 million Americans currently employed, workplaces provide ideal environments for implementation of sizable, cost-effective CVD prevention programs. However, successful wellness programming remains a laborious, resource intensive challenge for employers. In 2004, a National Worksite Health Promotion Survey disclosed that less than 7% of U.S. employers offered worksite wellness programs. Furthermore, an estimated 25-30% of companies' annual medical costs are spent on employees with CVD risk factors.
In the proposed study, a worksite wellness program that includes health assessments, personal health reports, and pedometer-based tracking of physical activity will be offered to university employees. Participants will not be randomized to an intervention or control group. Rather, program components will be available to all enrolled participants, and each individual may choose whether to wear a pedometer, track their step counts, attend wellness sessions, and/or complete the health assessments. There is no prescribed intervention. Wellness sessions include educational information on lifestyle behaviors to promote cardiometabolic health.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
Missouri
-
St. Louis, Missouri, Stati Uniti, 63108
- Washington University
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- employee of Washington University in St. Louis
Exclusion Criteria:
- pregnancy
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
---|---|
University employees
Participants will include employees of Washington University in St. Louis.
Recruitment will be directed to staff employees of the Central Fiscal Unit (CFU) on the Danforth campus.
|
The worksite wellness program included cardiovascular health assessments, personal health reports, 8 weeks of pedometer-based walking and tracking activities, and weekly wellness sessions.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Daily Step Count (determined by pedometer)
Lasso di tempo: Baseline, week 4, and week 8
|
Daily step counts, as recorded by pedometers, will be self-reported by participants for 7 continuous days at 3 study time points: baseline, week 4, and week 8.
|
Baseline, week 4, and week 8
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Body weight
Lasso di tempo: Baseline and week 9
|
Body weight will be measured on a digital scale in the morning after an overnight fast.
Shoes, jewelry, sweaters, jackets, belts, and hats will be removed and pockets will be emptied before the measurement is made.
|
Baseline and week 9
|
Body Mass Index (BMI)
Lasso di tempo: Baseline and week 9
|
BMI will be computed as weight in kilograms divided by height in meters squared.
Weight Status will be determined using standard CDC BMI categories.
|
Baseline and week 9
|
Body Composition
Lasso di tempo: Baseline and week 9
|
Fat mass (kg), fat free mass (kg), and percentage body fat will be determined by bioelectrical impedance analysis using the InBody 520 analyzer.
|
Baseline and week 9
|
waist circumference
Lasso di tempo: Baseline and week 9
|
Waist circumference will be measured at the border of the iliac crest using a Gulick II tape measure.
|
Baseline and week 9
|
Blood Pressure
Lasso di tempo: Baseline and week 9
|
Systolic and diastolic blood pressure will be measured in duplicate in the right arm after 10 minutes of seated rest using the Omron HEM-907XL Professional Digital Blood Pressure Monitors (Omron Healthcare, Kyoto, Japan).
One minute rest will be provided between the 2 measurements.
|
Baseline and week 9
|
Fasting plasma glucose
Lasso di tempo: Baseline and week 9
|
Fasting plasma glucose will be measured from a fingerstick blood sample in the morning after an overnight fast using the Cholestech LDX System® (Hayward, CA).
|
Baseline and week 9
|
Total Cholesterol
Lasso di tempo: Baseline and week 9
|
Total cholesterol will be quantified from a fingerstick blood sample in the morning after an overnight fast using the Cholestech LDX System® (Hayward, CA).
|
Baseline and week 9
|
LDL Cholesterol
Lasso di tempo: Baseline and week 9
|
LDL cholesterol will be computed using the Friedewald equation from the lipid profile measured from a fingerstick blood sample in the morning after an overnight fast using the Cholestech LDX System® (Hayward, CA).
|
Baseline and week 9
|
HDL Cholesterol
Lasso di tempo: Baseline and week 9
|
HDL cholesterol will be quantified from a fingerstick blood sample in the morning after an overnight fast using the Cholestech LDX System® (Hayward, CA).
|
Baseline and week 9
|
Triglycerides
Lasso di tempo: Baseline and week 9
|
Triglycerides will be quantified from a fingerstick blood sample in the morning after an overnight fast using the Cholestech LDX System® (Hayward, CA).
|
Baseline and week 9
|
Non-HDL Cholesterol
Lasso di tempo: Baseline and week 9
|
Non-HDL cholesterol will be computed by difference based on the lipid profile determined from a fasted fingerstick blood sample using the Cholestech LDX System® (Hayward, CA).
|
Baseline and week 9
|
Resting heart rate
Lasso di tempo: Baseline and week 9
|
Resting heart rate will be measured in duplicate in the morning after 10 minutes of seated rest using Omron HEM-907XL Professional Digital Blood Pressure Monitors (Omron Healthcare, Kyoto, Japan).
|
Baseline and week 9
|
Cardiorespiratory fitness based on post-exercise recovery heart rate
Lasso di tempo: Baseline and week 9
|
Cardiorespiratory fitness will be estimated based on heart rate recovery following a 3-minute step test performed with an 8-inch step and a metronome set to 96 beats/minute.
Participants will be instructed to maintain the pace set by the beat of the metronome for 3 consecutive minutes and to be seated immediately at the completion of the 3-minute test.
The subject's right radial pulse rate will be measured for 30 seconds, beginning 30 seconds after the completion of the test.
Cardiorespiratory fitness level will be computed based on sex- and age-specific heart rate criteria.
|
Baseline and week 9
|
Dietary patterns
Lasso di tempo: Baseline and week 9
|
Dietary patterns will be assessed using the nutrition questions from the CDC Behavioral Risk Factor Surveillance System (BRFSS).
|
Baseline and week 9
|
Physical activity patterns
Lasso di tempo: Baseline and week 9
|
Physical activity patterns will be assessed using the exercise questions from the CDC Behavioral Risk Factor Surveillance System (BRFSS).
|
Baseline and week 9
|
Perceived barriers to exercise participation
Lasso di tempo: Baseline and week 9
|
Perceived barriers to exercise participation will be assessed using the "Exercise Barriers" questionnaire, which the subject will complete on his/her own.
|
Baseline and week 9
|
Perceived benefits of exercise
Lasso di tempo: Baseline and week 9
|
Perceived benefits of exercise will be assessed using the "Exercise Benefits" questionnaire, which the subject will complete on his/her own.
|
Baseline and week 9
|
Participant evaluation of the wellness program
Lasso di tempo: Weeks 12 - 14
|
Participants will be asked to provide feedback about the wellness program through a 10-question, anonymous, online survey administered using the web-based Survey Monkey tool.
|
Weeks 12 - 14
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Susan B Racette, PhD, Washington University School of Medicine
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 201109022
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Physical activity
-
Istanbul Kültür UniversityMarmara University; Istanbul University - Cerrahpasa (IUC)CompletatoAttività fisica | Morbo di Parkinson | Bilancia | Cadente | KinesiofobiaTacchino
-
Rabin Medical CenterTerminatoDiabete di tipo 1Israele
-
University Hospital, ToulouseAttivo, non reclutante
-
prof dr Pieter GillardUniversity Colleges Leuven LimburgReclutamento
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); University of Rochester; University of Massachusetts...CompletatoCancro al seno | Sopravvissuto al cancro al seno | Tracker per il fitnessStati Uniti
-
Maastricht University Medical CenterSt. Antonius Hospital; Gelderse Vallei Hospital; ild care foundationCompletatoFatica | Sarcoidosi
-
University of BariProf. Maria GranoCompletato
-
Universiteit AntwerpenUniversity Hospital, Antwerp; Cliniques universitaires Saint-Luc- Université...CompletatoEmofilia A | Emofilia BBelgio
-
Istituto Auxologico ItalianoReclutamentoComportamento sanitarioItalia
-
Norwegian University of Science and TechnologyCompletatoMalattia cardiovascolare | ObesitàNorvegia